Dyfrig Hughes

14.1k total citations · 3 hit papers
260 papers, 9.0k citations indexed

About

Dyfrig Hughes is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Family Practice. According to data from OpenAlex, Dyfrig Hughes has authored 260 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Economics and Econometrics, 55 papers in Pediatrics, Perinatology and Child Health and 39 papers in Family Practice. Recurrent topics in Dyfrig Hughes's work include Health Systems, Economic Evaluations, Quality of Life (98 papers), Pharmaceutical Economics and Policy (48 papers) and Pharmaceutical studies and practices (40 papers). Dyfrig Hughes is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (98 papers), Pharmaceutical Economics and Policy (48 papers) and Pharmaceutical studies and practices (40 papers). Dyfrig Hughes collaborates with scholars based in United Kingdom, United States and Australia. Dyfrig Hughes's co-authors include Munir Pirmohamed, Bernard Vrijens, Sabina De Geest, Przemysław Kardas, Jeffrey K Aronson, Fabienne Dobbels, Emily Fargher, John Urquhart, Todd Ruppar and Paweł Lewek and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Dyfrig Hughes

246 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new taxonomy for describing and defining adherence to medications

2012 1.4k citations Bernard Vrijens, Dyfrig Hughes et al. British Journal of Clinical Pharmacology profile →
Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group

2015 345 citations Dyfrig Hughes et al. Value in Health profile →
ESPACOMP Medication Adherence Reporting Guideline (EMERGE)

2018 265 citations Jacqueline Dunbar‐Jacob, Dyfrig Hughes et al. profile →

Peers

Countries citing papers authored by Dyfrig Hughes

Since Specialization

Citations

This map shows the geographic impact of Dyfrig Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dyfrig Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dyfrig Hughes more than expected).

Fields of papers citing papers by Dyfrig Hughes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dyfrig Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dyfrig Hughes. The network helps show where Dyfrig Hughes may publish in the future.

Co-authorship network of co-authors of Dyfrig Hughes

This figure shows the co-authorship network connecting the top 25 collaborators of Dyfrig Hughes. A scholar is included among the top collaborators of Dyfrig Hughes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dyfrig Hughes. Dyfrig Hughes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of bias tools for medication adherence research: RoBIAS and RoBOAS 2025 ·British Journal of Clinical Pharmacology ·(unknown), Dyfrig Hughes, Sophie L. Stocker, Daniel F. B. Wright, (unknown)	0
2	Developing an alternative care pathway for emergency ambulance responses for adults with epilepsy: A Discrete Choice Experiment to understand which configuration service users prefer. Part of the COLLABORATE project 2024 ·Seizure ·Emily Holmes, Pete Dixon, A. McL Mathieson, Leone Ridsdale, Myfanwy Morgan, Alison McKinlay, Jon M Dickson, Steve Goodacre, (unknown), (unknown), (unknown), Steve Bell, Anthony G Marson, Dyfrig Hughes, Adam Noble	1
3	Evidence Following Conditional NICE Technology Appraisal Recommendations: A Critical Analysis of Methods, Quality and Risk of Bias 2024 ·PharmacoEconomics ·(unknown), Dyfrig Hughes	2
4	Service users' preferences and feasibility – which alternative care pathway for adult ambulance users achieves the optimal balance? Workshops for the COLLABORATE project 2024 ·Seizure ·Adam Noble, (unknown), Pete Dixon, A. McL Mathieson, Leone Ridsdale, Myfanwy Morgan, Jon M Dickson, Steve Goodacre, (unknown), Dyfrig Hughes, Anthony G Marson, Emily Holmes	1
5	The costs and cost-effectiveness of different service models of palliative care, focusing on end of life care: A rapid review 2024 ·medRxiv ·Llinos Haf Spencer, (unknown), (unknown), (unknown), Elizabeth Gillen, (unknown), Deborah Fitzsimmons, Ruth Lewis, Alison Cooper, Dyfrig Hughes, Rhiannon Tudor Edwards, Adrian Edwards	4
6	The experiences and perspectives of people with gout on urate self‐monitoring 2024 ·Health Expectations ·(unknown), (unknown), (unknown), Daniel F. B. Wright, (unknown), Dyfrig Hughes, Richard O. Day, Parisa Aslani, Sophie L. Stocker	1
7	Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study 2024 ·ACR Open Rheumatology ·(unknown), Daniel F. B. Wright, (unknown), (unknown), Parisa Aslani, Dyfrig Hughes, Richard O. Day, Sophie L. Stocker	3
8	Spanish translation of the ABC taxonomy for medication adherence 2023 ·Research in Social and Administrative Pharmacy ·Victoria García‐Cárdenas, Dyfrig Hughes, Isabel Aguilar‐Palacio, Shalom I. Benrimoj, María José Rabanaque, Fernando Martínez Martínez, Sara Malo	1
9	What interventions or best practice are there to support people with Long COVID, or similar post-viral conditions or conditions characterised by fatigue, to return to normal activities: a rapid review 2023 ·medRxiv ·Llinos Haf Spencer, Annie Hendry, (unknown), (unknown), (unknown), (unknown), Dyfrig Hughes, (unknown), Clare Wilkinson, Rhiannon Tudor Edwards, Ruth Lewis, Alison Cooper, Adrian Edwards	3
10	A framework for understanding sources of bias in medication adherence research 2023 ·British Journal of Clinical Pharmacology ·(unknown), Dyfrig Hughes, Sophie L. Stocker, Bernard Vrijens, Jeffrey K Aronson, Daniel F. B. Wright	4
11	Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit–risk assessment: the BRAINS study including expert workshop 2023 ·Health Technology Assessment ·Nikki Totton, Steven A. Julious, Elizabeth Coates, Dyfrig Hughes, Jonathan Cook, Katie Biggs, Catherine Hewitt, Simon Day, Andrew Cook	2
12	Methodological considerations on estimating medication adherence from self‐report, electronic monitoring and electronic healthcare databases using the TEOS framework 2022 ·British Journal of Clinical Pharmacology ·Alexandra L. Dima, Samuel Allemann, Jacqueline Dunbar‐Jacob, Dyfrig Hughes, Bernard Vrijens, Ira B. Wilson	11
13	Cost-effectiveness of home versus hospital management of children at onset of type 1 diabetes: the DECIDE randomised controlled trial 2021 ·BMJ Open ·(unknown), Julia Townson, Timothy Pickles, John W Gregory, Rebecca Playle, Michael Robling, Dyfrig Hughes	4
14	Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of Simplifying Assumptions 2020 ·PharmacoEconomics ·Ruth Lewis, Dyfrig Hughes, Alex J. Sutton, Clare Wilkinson	5
15	Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT 2020 ·Health Technology Assessment ·Conor Mallucci, Michael D. Jenkinson, Elizabeth J. Conroy, John C. Hartley, Michaela Brown, Tracy Moitt, (unknown), (unknown), Michael J. Griffiths, (unknown), Tom Solomon, Dyfrig Hughes, Carrol Gamble, (unknown)	12
16	A Fully Integrated Real-Time Detection, Diagnosis, and Control of Community Diarrheal Disease Clusters and Outbreaks (the INTEGRATE Project): Protocol for an Enhanced Surveillance System 2019 ·JMIR Research Protocols ·K. Marie McIntyre, F. J. Bolton, Robert Christley, Paul Cleary, (unknown), (unknown), Peter J. Diggle, Dyfrig Hughes, Simon de Lusignan, Lois Orton, Alan Radford, Alex J. Elliot, Gillian Smith, (unknown), Debbi Stanistreet, Roberto Vivancos, Craig Winstanley, S. O’Brien	4
17	35 Carer-administration of as-needed sub-cutaneous medication for breakthrough symptoms in homebased dying patients: a uk study (CARIAD) 2017 ·BMJ Supportive & Palliative Care ·Clare Wilkinson, (unknown), Jessica Roberts, Bee Wee, Julia Hiscock, Dyfrig Hughes, Annmarie Nelson, Paul Perkins, (unknown), (unknown), Betty Foster, Julie O’Connor, Siân Jones, Zoë Hoare, (unknown), Anthony Byrne, (unknown), Penney Lewis	1
18	Core Health Outcomes In Childhood Epilepsy (CHOICE): protocol for the selection of a core outcome set 2017 ·Trials ·Christopher Morris, Colin Dunkley, Frances Gibbon, (unknown), Debbie Roberts, Morwenna Rogers, Holly Crudgington, Lucy Bray, Bernie Carter, Dyfrig Hughes, Catrin Tudur Smith, Paula Williamson, Paul Gringras, Deb K. Pal	10
19	Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group 2013 ·Value in Health ·Femida Gwadry‐Sridhar, Elizabeth Manias, Lincy S. Lal, Maribel Salas, Dyfrig Hughes, Alexandria Ratzki‐Leewing, Maja Grubisić	119
20	Session 3C — Policy 2008 ·International Journal of Pharmacy Practice ·(unknown), Frederick W. Woodley, Derek Stewart, (unknown), M Fasihul Alam, Dyfrig Hughes, Frank Dunstan, Philip A. Routledge, Paul Fearn, Vikki Entwistle, Margaret Watson	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact